🔗 Visit the ClinicalTrials.gov page for NCT00882206
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia. | Am J Hematol | 2014 | 1.01 |
| 2 | The role of HDACs inhibitors in childhood and adolescence acute leukemias. | J Biomed Biotechnol | 2011 | 0.88 |
| 3 | Epigenetic modifications in pediatric acute lymphoblastic leukemia. | Front Pediatr | 2014 | 0.82 |
| 4 | Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia. | Curr Cancer Drug Targets | 2011 | 0.78 |
| 5 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |
| 6 | Histone deacetylase inhibitors: clinical implications for hematological malignancies. | Clin Epigenetics | 2010 | 0.76 |
| 7 | Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia. | Clin Epigenetics | 2015 | 0.75 |